You will find this little bit of information.
OPPENHEIMER FUNDS INC . 09/30/2015 - 0 - (7,000,000) - Sold Out
Yahoo data is old and they are slow to update changes, go to the NASDAQ site and look up Arena. On the left side select Institutional Ownership.
Now from there you have 2 ways to do it. Keep in mind that this data comes from the 13f which are due by the 15th of the month so not all have filed yet.
First way is to select the date and sort them by date, then you can go down and look at all of the 9/30 reported holdings.
Second way is to just select the Sold Out Tab.
You will see they did in fact sell out all of their holdings...
No its called Tax Loss Harvesting, but they sold the entire position so they can't buy it back for 31 days, so yes disturbing.
Not all tutes have reported but so far we are sitting at the following:
54.77% Tute Ownership
1,211,427 New Positions
7,687,517 Sold Out Positions
144 Tutes holding 132,682,728 shares
Again only half of the Tutes have been updated and are showing as of 9/30/15 13f reporting period.
Go to NASDAQ site and review the tute filings, the poster is correct as of 9/30/15 they closed out their position.
To UMA point, Hixson is not innocent and was in there right next to Jack making the bad decisions. The BOD sided with Jack, there was no evidence that their was infighting and disagreement on how the company was being managed. So I am not convinced that Hixson is the savior everyone is hoping for.
2.50 to 3.00 after the CC is going to be very difficult, unless they have a few surprises for us. So your post is a little more then speculation. The 10Q had some great news, filing in Taiwan, a beat of .02 or .03 depending on how you look at it. Yet the focus will be Arena will need to raise cash, the cut in burn is to little to late.
That is pure speculation, lets deal in facts here. The activity at Arena is the same activity that has been going on for the last year. Only changes so far is that Jack was fired and it is going to cost us 2 million to get rid of that worthless piece of flesh, and that we are laying off 80 researchers. That will slow the burn, we still blew thru what 340 million the last 3 years and have nothing to show for it.. Wall Street now has all the information they need. Arena is on the ropes and will have to raise cash in the next 12 months. It will be a race, can Arena get the 6 drugs through the proof of concept with good enough results to get partners in to inject needed cash in 12 months or will Arena break down and dilute like mad for their needed working capital...
I posted earlier that we are already down this rabbit hole just run the company to 100 million if we are going to end up with 5 or 6 drugs with stellar results from the Phase 2 studies. The need for cash will put a weight on the stock price and create massive short games since a dilution is almost assured.
Did you read about the filing in Taiwan? That was good news and not expected. CYB filed in Taiwan. Soon we will have another market.
Termanogrel is not our study and it being done by one of our collaborators. Just like with Axon, so don't read anything into that. Axon is moving forward with their Phase 2 and we are doing nothing with it, same situation with Temanogrel.
You might want to re read the post. The point was that Ildong and the Swiss factory doing as much as our marketing partner that controls the entire US market.
No way for it to be anything else and this is why Jack needed to be fired. Personally I wish he could be sued personally for being a dip cheat and destroying Arena Pharma with his bad decisions...
Eisai does not care and neither does Arena. They will not hold Eisai accountable because Eisai is on the hook for spending 90% of CVOT and MACE studies. That is a significant amount of money. To bad Eisai are a bunch of morons.......
Wrong, the ticker is not dead, how short sighted. You think the price wilk stay down as we move towards major catalysts? Shows you don't know the game. We will moce up into the events and we have a lot of them.... NDA Belviq XR, refiling EU before March of 2016, weight loss season kicking in, 3 quarter completion if the first Phase 2 srudies going into end of 4th quarter with the rest completing and reporting. At that point if positive we move up on partnerships or potential buyouts or selling off of the entire deug to raise money.
The sad thing is the market has priced us at almost par with OREX and they have diddly squat.... We have science, patents, a pipeline and a new and novel drug that has multiple indications.... And with the right partner Lorc would be scripted for smoking, weight loss, NASH, drug addiction and who knows what else.